162.17USD+2.67%Mkt Cap: 4.05B $P/E: 87.191d ago
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products …
Industry Peers
Medical Instruments & Supplies$142.49BUSDP/E 48.8
$84.67BUSDP/E 34.0
$73.25BUSDP/E 36.1
$44.07BUSDP/E 27.9
$31.69BUSDP/E 42.2
$29.41BUSDP/E 19.6
$25.61BUSDP/E 48.5
$19.82BUSDP/E 67.9
$18.23BUSDP/E 44.9
$18.54BUSDP/E 105.1
$14.74BUSDP/E 83.6
$13.59BUSDP/E 44.2
$14.26BUSDP/E 61.9
$14.15BUSDP/E 10.0
$12.78BUSDP/E 30.0
$12.06BUSD
$8.60BUSDP/E 23.1
$8.38BUSDP/E 165.1
$7.69BUSD
$5.63BUSDP/E 23.0
$5.99BUSDP/E 1931.7
$4.53BUSDP/E 30.5
$4.51BUSDP/E 32.6
$4.46BUSD
$4.39BUSDP/E 65.8
$4.03BUSDP/E 40.3
$3.67BUSDP/E 16.5
$3.32BUSDP/E 21.4
$3.39BUSDP/E 2759.0
$2.85BUSDP/E 21.9
$2.63BUSD
$2.77BUSD
$2.35BUSDP/E 37.9
$1.95BUSDP/E 36.0
$1.89BUSD
$1.80BUSD
$1.48BUSD
$1.44BUSD
$1.29BUSDP/E 74.9
$1.41BUSD
$1.23BUSD
$1.09BUSD
$752.64MUSDP/E 16.0
$811.83MUSD
$756.96MUSDP/E 14.8
$671.62MUSDP/E 39.2
$660.94MUSDP/E 55.9
$584.44MUSD
$360.76MUSDP/E 21.2
$354.68MUSDP/E 17.1
$272.64MUSD
$245.88MUSDP/E 13.6
$232.03MUSDP/E 422.0
$211.00MUSDP/E 35.6
$228.42MUSDP/E 21.2
$198.25MUSDP/E 23.8
$198.75MUSDP/E 1.8
$194.76MUSD
$188.63MUSDP/E 16.3
$160.12MUSD
$164.06MUSD
$123.68MUSDP/E 39.3
$115.11MUSD
$120.22MUSD
$107.50MUSD
$61.36MUSDP/E 6.4
$59.94MUSD
$48.70MUSD
$40.82MUSDP/E 53.7
$41.23MUSDP/E 41.0
$37.15MUSD
$32.43MUSD
$26.84MUSD
$25.35MUSDP/E 176.7
$20.69MUSD
$18.82MUSD
$14.75MUSD
$14.58MUSD
$13.43MUSD
$9.21MUSD
$7.52MUSDP/E 12.9
$7.46MUSD
$5.06MUSD
$4.00MUSD
$465.9KUSD
$138.6KUSD
Indicators:|
Key Statistics
Company
Market Cap4.05B $
Enterprise Value5.00B $
Revenue (TTM)2.16B $
Gross Profit822.04M $
Net Income (TTM)732.00K $
Revenue/Share87.33 USD
Last Price162.17 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees13.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)87.19
P/E (Forward)17.37
PEG0.09
EV/EBITDA16.05
EV/Revenue2.32
P/S1.88
P/B1.92
EPS (TTM)1.86
EPS (Forward)9.34
52W Range
107.0099% of range162.78
52W High162.78 USD
52W Low107.00 USD
Profitability
Gross Margin36.84%
Oper. Margin5.73%
EBITDA Margin14.44%
Profit Margin0.03%
ROE0.03%
ROA0.02%
Growth
Revenue Growth-12.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF179.85M $
CapEx (TTM)97.02M $
FCF Margin17.95%
FCF Yield9.55%
Net Debt1.05B $
Net Debt/EBITDA3.37
Balance Sheet
Debt/Equity0.63
Current Ratio2.34
Quick Ratio0.95
Book Value/Sh84.50 USD
Cash/Share11.71 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split3:2
Split DateMar 18, 2002
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)174.38 USD
Upside (mean)+7.5%
Target Range163.00 USD – 200.00 USD
$163.00+7.5% to mean$200.00
# Analysts8
Ownership
Shares Out.24.99M
Float24.51M
Insiders1.92%
Institutions114.93%
Short Interest
Short Ratio5.4d
Short % Float8.08%
Short % Out.6.74%
Shares Short1.69M
Short (prev mo.)1.84M
Technical
SMA 50137.88 (+17.6%)
SMA 200136.65 (+18.7%)
Beta0.76
S&P 52W Chg20.25%
Avg Vol (30d)278.84K
Avg Vol (10d)276.06K
Technical Indicators
RSI (14)67.2
MACD5.9131
MACD Signal5.4111
MACD Hist.+0.5020
BB Upper165.58 USD
BB Middle149.37 USD
BB Lower133.16 USD
BB Width21.70%
ATR (14)5.327 USD
Vol Ratio (20d)0.99x